DailyMed label
BUPRENORPHINE AND NALOXONE
DailyMed label · Ascend Laboratories, LLC · version 19
Key facts
| Product | BUPRENORPHINE AND NALOXONE |
|---|---|
| Labeler | Ascend Laboratories, LLC |
| Document type | Human Prescription Drug Label |
| Active ingredients | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE |
| Active ingredient UNIIs | 56W8MW3EN1, F850569PQR |
| Application number | 214930 |
| Route | SUBLINGUAL |
| DEA schedule | CIII |
| NDC package codes | 67877-607-30, 67877-607-90, 67877-607-84, 67877-606-30, 67877-606-90, 67877-606-84 |
| Effective date | Jun 29, 2026 |
| Set ID | 2e807ed0-6df3-47b5-b7ee-b421c5bf0aa7 |
At a glance
- 1–9 NDC package codes
- 1–9 Active ingredients
- 1–9 Manufacturing establishments listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About DailyMed drug labels
DailyMed publishes the structured product labeling (SPL) that companies submit to the FDA, including package NDCs, ingredients and the establishments that make each product.
Source: U.S. National Library of Medicine (NLM), DailyMed · Source date: